期刊文献+

一例罕见的新的TCIRG1基因杂合性突变引起的婴儿恶性石骨症 被引量:11

An unusual and novel heterozygous TCIRG1 mutation causes infantile malignant osteopetrosis
下载PDF
导出
摘要 目的:研究1例婴儿恶性石骨症患者的致病基因及其突变。TCIRG1和CLCN7是婴儿恶性石骨症最常见的致病基因。前者被认为是纯合性致病基因,国外只有6例其杂合性改变也致本病的报导,而我国无杂合性突变导致本病的报道。方法:通过骨组织X线检查结合临床症状及体征确诊1例散发性婴儿恶性石骨症患者。提取患者及其父母的外周血基因组DNA,PCR扩增TCIRG1和CLCN7基因外显子及其剪切位点序列,对PCR产物直接测序。用TCRIG1基因附近的微卫星标记和SNP构建患者及其父母的单倍型。用染色体微阵列分析技术对患者及其母亲进行TCIRG1基因拷贝数目变异的检测。结果:患者TCIRG1基因第5号外显子内发现一个4个碱基的缺失突变c.449_452del AGAG(p.Gln149Glnfs16),该突变使得基因3’端编码的666个氨基酸被截断,失去了整个ATP酶V0复合结构域。患儿双亲TCIRG1和CLCN7基因的突变检测及单倍体构建证实该突变来源于患者父亲。染色体微阵列分析未发现患儿及其母亲携带有任何累及TCIRG1及CLCN7基因的拷贝数目变异。结论:本研究发现了1例TCIRG1基因新的杂合性突变所致的婴儿恶性石骨症。这是我国TCIRG1基因杂合性突变引起婴儿恶性石骨症的首例报道。这个发现可用于婴儿恶性石骨症的分子诊断。 AIM: To investigate the underlying genetic changes of a Chinese patient with infantile malignant osteopetrosis( IMO). IMO is a monogenic disease,mostly caused by mutations of TCIRG1 and CLCN7 genes. The former is believed a homozygous gene and only cause the disease in homozygous or compound heterozygous status. However,it has been reported that heterozygous mutations also cause the disease in 6 non-Chinese cases. METHODS: Genomic DNA was extracted from peripheral blood of the patient and his parents. All exons and splice sites of TCIRG1 and CLCN7 genes were amplified by PCR followed by Sanger sequencing. Mutation detection in the 2 genes was also investigated in the parents.Haplotypes were constructed by variations obtained in mutation detection and microsatillites flanking TCIRG1 gene in the family by Cyrillic. Chromosomal microarray analysis( CMA) was performed to detect copy number variations( CNV) of the patient and his mother. RESULTS: A novel mutation c. 449_452del AGAG( p. Gln149Glnfs16) was detected in the patient. This mutation truncated 666 amino acids at the C terminal of the V-ATPase 116 k D isoform a3 protein. It wiped out the entire ATPase V0 complex and was predicted to result in total loss of protein function. This mutation was also detected in the patient's father. No pathogenic mutation was detected in CLCN7 gene. CMA did not reveal any CNV involving TCIRG1 or CLCN7 gene. CONCLUSION: We reported a novel heterozygous mutation of TCIRG1 gene causing IMO. This represents the first IMO case in China caused by heterozygous TCIRG1 gene mutation.
出处 《中国病理生理杂志》 CAS CSCD 北大核心 2015年第7期1237-1241,共5页 Chinese Journal of Pathophysiology
基金 国家自然科学基金资助项目(No.31471193)
关键词 婴儿恶性石骨症 TCIRG1基因 缺失突变 Infantile malignant osteopetrosis TCIRG1 gene Deletion mutation
  • 相关文献

参考文献13

  • 1Sobacchi C, Schulz A, Coxon FP, et al. Osteopetrosis : genetics, treatment and new insights into osteoclast func- tion[J]. Nat Rev Endocrinol,2013,9(9):522-536.
  • 2Stark Z, Savarirayan R. Osteopetrosis [ J ]. Orphanet J Rare Dis ,2009,4:5.
  • 3Scimeca JC, Quincey D, Parrinello H, et al. Novel muta- tions in the TCIRG1 gene encoding the a3 subunit of the vacuolar proton pump in patients affected by infantile ma- lignant osteopetrosis [ J ]. Hum Mutat, 2003,21 ( 2 ) : 151- 157.
  • 4Frattini A, Pangrazio A, Susani L, et al. Chloride chan- nel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis [ J ]. J Bone Miner Res ,2003 ,18 (10) : 1740-1747.
  • 5Nishi T, Forgac M. The vacuolar (H +)-ATPases: na- ture' s most versatile proton pumps [ J ]. Nat Rev Mol Cell Biol,2002,3 (2) :94-103.
  • 6Kornak U, Kasper D, Bosl MR, et al. Loss of the C1C-7 chloride channel leads to osteopetrosis in mice and man [J]. Cell,2001,104(2) :205-215.
  • 7Wada K, Harada D, Michigami T, et al. A case of auto- somal dominant osteopetrosis type II with a novel TCIRG1 gene mutation[ J ]. J Pediatr Endocrinol Metab, 2013,26 (5-6) :575-577.
  • 8Kornak U, Schulz A, Friedrich W, et al. Mutations in the a3 subunit of the vacuolar H + -ATPase cause infantile ma- lignant osteopetrosis[J]. Hum Mol Genet,2000,9(13) : 2059-2063.
  • 9Sobaechi C, Frattini A, Orchard P, et al. The mutational spectrum of human malignant autosomal recessive osteope- trosis[ J]. Hum Mol Genet,2001,10(17) : 1767-1773.
  • 10邓佳,邓伟平,钟诚,胡彬,王一鸣.NF1基因新突变及我国首例NF1基因拷贝数目变异报道[J].中国病理生理杂志,2013,29(2):320-323. 被引量:3

二级参考文献19

  • 1Townson JR,Barcellos LF,Nibbs RJ.Gene copy number regulates the production of the human chemokine CCL3-L1[J].Eur J Immunol,2002,32(10):3016-3026.
  • 2Gonzalez E,Kulkarni H,Bolivar H,et al.The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility[J].Science,2005,307(5714):1434-1440.
  • 3Williams VC,Lucas J,Babcock MA. Neurofibromatosis type 1 revisited[J].Pediatrics,2009,(01):124-133.doi:10.1542/peds.2007-3204.
  • 4Mautner VF,Kluwe L,Friedrich RE. Clinical characterisation of 29 neurofibromatosis type-1 patients with molecularly ascertained 1.4 Mb type-1 NF1 deletions[J].Journal of Medical Genetics,2010,(09):623-630.
  • 5Pasmant E,Sabbagh A,Spurlock G. NF1 microdeletions in neurofibromatosis type 1:from genotype to phenotype[J].Human Mutation,2010,(06):E1506-E1518.
  • 6Thiagalingam S,Flaherty M,Billson F. Neurofibromatosis type 1 and optic pathway gliomas:follow-up of 54 patients[J].Ophthalmology,2004,(03):568-577.
  • 7Graf N. Glioblastoma in children with NF1:the need for basic research[J].Pediatric Blood & Cancer,2010,(07):870-871.
  • 8McCaughan JA,Holloway SM,Davidson R. Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1[J].Journal of Medical Genetics,2007,(07):463-466.
  • 9L(a)zaro C,Ravella A,Gaona A. Neurofibromatosis type 1 due to germ-line mosaicism in a clinically normal father[J].New England Journal of Medicine,1994,(21):1403-1407.
  • 10Hezel AF,Deshpande V,Zhu AX. Genetics of biliary tract cancers and emerging targeted therapies[J].Journal of Clinical Oncology,2010,(21):3531-3540.

共引文献6

同被引文献85

  • 1秦茂权,吴敏媛,王彬,张莉,段彦龙,金眉,冯涛,崔春华,周翾,张永红.CD_(34)^+细胞分选的无血缘相关供者造血干细胞移植成功治疗儿童石骨症1例[J].中国小儿血液与肿瘤杂志,2007,12(4):150-152. 被引量:7
  • 2唐湘凤,栾佐,吴南海,徐世侠,黄友章,屈素清,胡晓红,刘卫鹏.非血缘脐血干细胞移植治疗恶性婴儿型石骨症1例报道[J].中国当代儿科杂志,2007,9(6):612-613. 被引量:3
  • 3Rachner TD, Khosla S, Hotbauer LC. Osteoporosis: now and the future. Lancet, 2011, 377 (9773) : 1276-1287.
  • 4Coudert AE, de Vernejoul MC, Muraca M, De1 Fattore A. Osteopetrosis and its relevance for the discovery of new func- tions associated with the skeleton. Int J Endocrinol, 2015, 2015 : 372156.
  • 5Roberts CM, Angus JE, Leach IH, McDermott EM, Walker DA, Ravenscroft JC. A novel NEMO gene mutation causing osteo- petrosis, lymphoedema, hypohidrotic ectodermal dysplasia and immunodeficiency (OL-HED-ID). Eur J Pediatr, 2010, 169 (11) : 1403-1407.
  • 6Mahmoud Adel AH, Abdullah AA, Eissa F. Infantile osteopetro- sis, craniosynostosis, and Chiari malformation type I with novel OSTEMI mutation. J Pediatr Neurosci, 2013, 8 ( 1 ) : 34-37.
  • 7Wada K, Harada D, Michigami T, Tachikawa K, Nakano Y, Kashiwagi H, Yamashita S, Sano T, Seino Y. A case of autoso- mal dominant osteopetrosis type II with a novel TCIRG1 gene mu- tation. J Pediatr Endocrinol Metab, 2013, 26 (5-6) : 575-577.
  • 8Kant P, Sharda N, Bhowate RR. Clinical and radiological find- ings of autosomal dominant osteopetrosis type II: a case re- port. Case Rep Dent, 2013, 2013 : 707343.
  • 9van Hove RP, de Jong T, Nolte PA. Autosomal dominant type I osteopetrosis is related with iatrogenic fractures in arthroplas- ty. Clin Orthop Surg, 2014, 6 (4) : 484-488.
  • 10Alam I, Gray AK, Chu K, Ichikawa S, Mohammad KS, Capan- nolo M, Capulli M, Maurizi A, Muraca M, Teti A, Econs MJ, Del Fattore A. Generation of the first autosomal dominant osteope- trosis type II (ADO2) disease models. Bone, 2014, 59: 66-75.

引证文献11

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部